Moximed is a trailblazing brand that aims to create a new beginning for patients suffering from osteoarthritis. They have developed the MISHA Knee System, a platform of implantable shock absorbers that provide positive patient outcomes. The system is the culmination of years of research, experience, and innovation.

Founded in 2008, Moximed recognized the significance of load management as a tool against knee OA when others did not. With unparalleled persistence and support from surgeons, they designed an implantable shock absorber that has demonstrated clear clinical value. In 2014, they introduced the MISHA Knee System, which incorporates the latest technology and insights gained through experience.

Leading the charge at Moximed is an exceptional leadership team, including CEO Anton Clifford, who invented the implantable shock absorber, and CFO Debra Snowdale, a seasoned executive with expertise in high-growth medical device companies. Together, they are dedicated to providing innovative solutions and improving the lives of patients. Join Moximed on their journey to revolutionize knee OA treatment and make a significant impact on the lives of patients worldwide